What does CUSIP 78349D107 represent in this 13F holders report?

CUSIP 78349D107 is the security identifier for RXST - RxSight, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held RXST - RxSight, Inc. - Common Stock, par value $0.001 per share in Q2 2022?

47 institutional investors reported RXST - RxSight, Inc. - Common Stock, par value $0.001 per share for Q2 2022. Use the holders table for investor-level position and value details.

RxSight, Inc. - Common Stock, par value $0.001 per share (RXST)

CUSIP: 78349D107

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 9,305,838
Total 13F value: $131,026,291
Share change: +555,624
SEC-reported price per share: $14.08
Number of holders: 47
Value change: +$7,946,345
Number of buys: 33
Number of sells: 13
Shares outstanding: 41,457,800

Security key

78349D107

Report period

Q2 2022

Institutions

Top holders

RXST full security history Ownership snapshot Full 13F holder table RxSight, Inc. SEC filings RxSight, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RXST - RxSight, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

31 Mar 2022

13F 3/4/5 Lead comparable stake: 7.4% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 7.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 7.4%

ORBIMED ADVISORS LLC 3.3%

MILLENNIUM MANAGEMENT LLC 2.3%

BlackRock Finance, Inc. 1.8%

VANGUARD GROUP INC 1.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	7.4%	$37,794,000 3,052,796 shares	—	31 Mar 2022
ORBIMED ADVISORS LLC	13F Company 13F	3.3%	$17,128,000 1,383,500 shares	—	31 Mar 2022
MILLENNIUM MANAGEMENT LLC	13F Company 13F	2.3%	$11,690,000 944,280 shares	—	31 Mar 2022
BlackRock Finance, Inc.	13F Company 13F	1.8%	$9,106,000 735,589 shares	—	31 Mar 2022
VANGUARD GROUP INC	13F Company 13F	1.5%	$7,908,000 638,813 shares	—	31 Mar 2022
Cresset Asset Management, LLC	13F Company 13F	0.76%	$3,909,000 315,719 shares	—	31 Mar 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

9,305,838

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q2 2022 value	Value change	Value Chg %